Research has shown that CD36 expression is significantly reduced in pancreatic cancer cell lines and tumor tissues, which may enhance tumor cell motility by weakening ECM adhesion and collagen-binding capacity, thereby promoting metastasis and poor prognosis (79, 80). This evidence concerns the gene CD36 and neoplasm.